Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company

Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company

Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company Provides Futher Information on Newscope Transaction MONTREAL, Nov. 08, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has executed a letter of intent to acquire a Montreal based biopharma contract manufacturing company through its wholly owned subsidiary BGX e-Health LLC. The transaction is subject to customary due diligence and the parties have agreed to keep the vendors information confidential until such a time when the definitive agreement is executed. The target of the transaction is a Montreal based Biopharma company that manufactures for private label, white label and for its own brands of over the counter health products sold in Canada and the US. The acquisition of the target represents a strategic vertical integration for BGX E-Health, and it is forecasted to have a material impact on the subsidiary’s revenues and a significant increase in gross margins, while providing at the same time immediate access to lucrative news opportunities. The addition of the target will also allow the company to pursue private label solutions in North America and its laboratories will enable the company to conduct…

Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.